申请人:BANYU PHARMACEUTICAL CO., LTD.
公开号:EP1734040A1
公开(公告)日:2006-12-20
The present invention provides a compound having a glucokinase activating action being useful for prevention or treatment of diabetes mellitus, etc. being represented by the formula (I):
X is nitrogen atom, etc.; Y is oxygen atom, etc.; R1 is an optionally substituted five to six-membered heteroaryl group, etc.; R2 is hydrogen atom or fluorine atom; and ring A is a monocyclic or bicyclic heteroaryl group which may have a substituent represented by the formula (II)]
or a pharmaceutically acceptable salt thereof.
本发明提供了一种具有葡萄糖激酶激活作用的化合物,可用于预防或治疗糖尿病等,由式(I)表示:
X为氮原子等;Y为氧原子等;R1为任选取代的五至六元杂芳基等;R2为氢原子或氟原子;环A为单环或双环杂芳基,可具有由式(II)代表的取代基]。
或其药学上可接受的盐。